Treatment with multi-species probiotics changes the functions, not the composition of gut microbiota in postmenopausal women with obesity: a randomized, double-blind, placebo-controlled study
2022-03-11·,,,,,
,·
0 min read
Mariusz Kaczmarczyk
Monika Szulińska
Igor Łoniewski
Matylda Kręgielska-Narożna
Karolina Skonieczna-Żydecka
Tomasz Kosciolek
Valentyn Bezshapkin
Paweł Bogdański
Abstract
Probiotics are known to regulate host metabolism. In randomized controlled trial we aimed to assess whether interventions with probiotic containing following strains: Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Bifidobacterium lactis W52, Lactobacillus acidophilus W37, Levilactobacillus brevis W63, Lacticaseibacillus casei W56, Ligilactobacillus salivarius W24, Lactococcus lactis W19, and Lactococcus lactis W58 affect gut microbiota to promote metabolic effects. Probiotic intervention alters the influence of microbiota on biochemical, physiological and immunological parameters, but it does not affect diversity and taxonomic composition. Baseline microbiota is not a predictor of therapeutic response to a multispecies probiotic.
Publication
Frontiers in Cellular and Infection Microbiology

Authors
Valentyn Bezshapkin
(he/him)
MD, PhD Researcher in Bioinformatics
MD and PhD student in Bioinformatics at ETH Zürich, applying deep learning
and computational methods to decode the human gut microbiome. Building tools
that bridge metagenomics, machine learning, and clinical insights.